Malinconico et al., 1984 - Google Patents
Hementin: anticoagulant protease from the salivary gland of the leech Haementeria ghilianiiMalinconico et al., 1984
- Document ID
- 12558725020954797648
- Author
- Malinconico S
- Katz J
- Budzynski A
- Publication year
- Publication venue
- The Journal of laboratory and clinical medicine
External Links
Snippet
Leech Haementeria ghilianii has an anticoagulant in its salivary glands that renders ingested blood incoagulable by thrombin. The mechanism of blood incoagulation is associated with cleavage of peptide bonds in fibrinogen, and thus the active agent, called …
- 108010005808 hementin 0 title abstract description 149
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6424—Serine endopeptidases (3.4.21)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/914—Hydrolases (3)
- G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
- G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
- G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
- G01N2333/96425—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
- G01N2333/96427—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6402—Proteinases Endopeptidases (3.4.21-3.4.25) derived from animal tissue from non-mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/81—Protease inhibitors
- G01N2333/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
- G01N2333/811—Serine protease (E.C. 3.4.21) inhibitors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Malinconico et al. | Hementin: anticoagulant protease from the salivary gland of the leech Haementeria ghilianii | |
Palascak et al. | Dysfibrinogenemia associated with liver disease | |
Aoki et al. | Inhibitors of the fibrinolytic enzyme system | |
Sakata et al. | Cross-linking of alpha 2-plasmin inhibitor to fibrin by fibrin-stabilizing factor. | |
Willis et al. | Purification and biochemical characterization of atroxase, a nonhemorrhagic fibrinolytic protease from western diamondback rattlesnake venom | |
Scott et al. | Inactivation of factor XIa by plasma protease inhibitors: predominant role of α 1-protease inhibitor and protective effect of high molecular weight kininogen | |
Mimuro et al. | Extracellular matrix of cultured bovine aortic endothelial cells contains functionally active type 1 plasminogen activator inhibitor | |
Martinoli et al. | Fast functional protein C assay using protac® a novel protein C activator | |
Stocker et al. | Characterization of the protein C activator Protac® from the venom of the southern copperhead (Agkistrodon contortrix) snake | |
Chesney et al. | Human platelet collagenase | |
Phillips et al. | Thrombin substrates and the proteolytic site of thrombin action on human-platelet plasma membranes | |
Hedner | Studies on an inhibitor of plasminogen activation in human serum | |
Siigur et al. | Biochemical characterization of lebetase, a direct-acting fibrinolytic enzyme from Vipera lebetina snake venom | |
Levin et al. | Aspirin inhibits vascular plasminogen activator activity in vivo. Studies utilizing a new assay to quantify plasminogen activator activity. | |
Budzynski et al. | Fibrinogenolytic afibrinogenemia after envenomation by western diamondback rattlesnake (Crotalus atrox) | |
Kluft et al. | alpha 2-Antiplasmin Enschede: dysfunctional alpha 2-antiplasmin molecule associated with an autosomal recessive hemorrhagic disorder. | |
Rosenberg | The effect of heparin on factor XIa and plasmin | |
Booth et al. | Plasminogen activator inhibitor from human endothelial cells: purification and partial characterization | |
Kane et al. | Activation of coagulation factor V by a platelet protease | |
Budzynski et al. | Anticoagulant and fibrinolytic properties of salivary proteins from the leech Haementeria ghilianii | |
Ouyang et al. | Physicochemical properties of α-and β-fibrinogenases of Trimeresurus mucrosquamatus venom | |
US4390630A (en) | Hementin--a fibrinolytic agent | |
Semar et al. | Partial purification and properties of a plasminogen activator from human erythrocytes | |
Laake et al. | Determination of factor XII in human plasma with arginine proesterase (prekallikrein) I. Preparation and properties of the substrate | |
Malinconico et al. | Fibrinogen degradation by hementin, a fibrinogenolytic anticoagulant from the salivary glands of the leech Haementeria ghilianii |